The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Currie Medical Specialties sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Currie Medical Specialties is a medical device company that designs, manufactures, and markets pneumatic compression devices and garments for the prevention of deep vein thrombosis (DVT). Its key product, ALP Venous Thromboembolism Prevention System (ALP System) is a non-invasive external intermittent pneumatic compression system used as prophylaxis for reducing the incidence of DVT. It also offers designed garments to paediatric patients for pneumatic compression in order to prevent VTE. The ALP consists of a pneumatic compression pump and a range of breathable garments, including foot, calf-length, and thigh-length. Currie Medical is headquartered in Franklin, Tennessee, the US.
The key metrics of Currie Medical Specialties related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Currie Medical Specialties is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Currie Medical Specialties.
For a detailed understanding of the performance of Currie Medical Specialties, buy the report here.